A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
IVD Antibody Development Services for BCL-2 Marker - Creative Biolabs
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer | Scientific Reports
Noncanonical Cell Fate Regulation by Bcl-2 Proteins: Trends in Cell Biology
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia | Haematologica
Bcl-2 as a clinical prognostic marker. | Download Table
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
IJMS | Free Full-Text | Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer | HTML
Targeting BCL2 for the Treatment of Lymphoid Malignancies - ScienceDirect
Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: A retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant
Bcl-2 - Wikipedia
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | Scientific Reports
PDF) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | ResearchGate
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL - ScienceDirect
Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
